The new Republican Congress is naturally antipathetic to the US Food and Drug Administration, but radical change will not be easily accomplished, which is just as well.
This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
End of the line in sight for PDA?. Nature 376, 713–714 (1995). https://doi.org/10.1038/376713a0
Issue Date:
DOI: https://doi.org/10.1038/376713a0
- Springer Nature Limited